Navigation Links
Tianyin Reports Record Fiscal 2010 Financial Results
Date:9/29/2010

ns 14,746,137 9,716,595 Other income (expenses): Interest (expense) income, net (26,649) 261,463 Impairment loss on intangible assets -- (431,344) Other expenses (39,518) -- Total other expenses (65,167) (169,881) Income before provision for income taxes 14,680,970 9,546,714 Provision for income taxes 2,626,143 1,639,104 Net income 12,054,827 7,907,610 Less: Net income attributable to noncontrolling interest 11,677 -- Net income attributable to Tianyin Pharmaceutical Co., Inc. 12,043,150 7,907,610 Other comprehensive income Foreign currency translation adjustment 293,696 73,506 Comprehensive income $12,336,846 $7,981,116 Basic earnings per share $0.47 $0.41 Diluted earnings per share $0.40 $0.32 Weighted average number of common shares outstanding: Basic 24,427,329 15,937,411 Diluted 30,081,685 24,805,281 Consolidated Statements of Cash Flows For the Years Ended June 30, 2010 2009 Cash flows from operating activities: Net Income $12,043,150 $7,907,610 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 953,767 676,605 Provision for bad debts 247,131 81,512 Loss on disposal of fixed assets 39,518 -- Impairment loss on intangible assets -- 431,344 Stock-based payments 1,037,686 249,026 Noncontrolling interest 11,677 -- Changes in current assets and current liabilities: Accounts receivable (2,770,322) (1,223,282) Inventory 239,233 (237,975) Other current assets 606,785 (62,705) Accounts payable and accrued expenses 315,202 49,867 Accounts payable - construction related 2,239,231 -- VAT taxes payable 222,833 180,701 Income tax payable 366,845 147,897 Other taxes payable (19,223) (28,213) Dividend payable (252,422) -- Other current liabilities 119,007 164,611 Total adjustments 3,356,948 429,388 Net cash provided by operating activities 15,400,098 8,336,998 Cash flows from investing activities: Loans receivable (293,340) -- Additions to property and equipment (59,946) (58,014) Additions to construction
'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Tianyin Corporate Presentation Updated
2. Tianyin Reports Record Third Quarter 2010 Financial Results
3. Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16
4. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
5. Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services
6. Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results
7. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET
9. Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
10. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
11. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Massachusetts , September 19, 2014 ... the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting  ... of science and medical research in the field of ... Merck KGaA, Darmstadt, Germany , today ... Innovation (GGI) for 2014. The awards were announced during ...
(Date:9/18/2014)... -- About POCT POCT, also ... laboratory. It helps in making fast clinical decisions, ... POCT is gaining popularity due to the increasing ... diabetes, heart disease, and obesity. It is generally ... minimize errors during the diagnosis of patients. POCT ...
(Date:9/18/2014)... September 18, 2014 ... http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced the addition ... Global Strategic Business Report" report ... ,This report analyzes the worldwide markets ... by the following Product Segments: Polymeric ...
(Date:9/18/2014)... , Sept. 18, 2014 ... of the "Global N-acetylcysteine Industry Report 2014" ... The Global N-acetylcysteine Industry Report 2014 is a ... of the global N-acetylcysteine industry. The ... including definitions, classifications, applications and industry chain structure. ...
Breaking Biology Technology:EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global N-acetylcysteine Industry Report 2014 2
... TORONTO, April 3, 2012  Generex Biotechnology Corporation (OTCBB: GNBT.OB) ... (AACR) chose to spotlight a presentation on data from ... to prevent relapse in patients who have had breast ... conference.  The annual AACR meeting is one of the ...
... CAMBRIDGE, Mass., April 2, 2012   Good Start Genetics ,™ ... standard in carrier screening , today announced it completed ... Stock financing, which was led by existing investors OrbiMed ... SFE ) and SV Life Sciences . Proceeds from ...
... important step forward in developing a new material using nano-sized ... devices, with greater capacity than is currently feasible, in a ... Many modern data storage devices, like hard disk ... tiny individual magnetic sections, but their overall design is limited ...
Cached Biology Technology:Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer 2Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer 3Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer 4Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 2Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 3Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 4Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 5Honeycombs of magnets could lead to new type of computer processing 2Honeycombs of magnets could lead to new type of computer processing 3
(Date:9/19/2014)... a species which over thousands of years has adapted to ... substance that makes the cold dangerous for you. , This ... , and the cold provoking substance, called nonylphenol, comes from ... is suspected of being a endocrine disruptor, but when entering ... worm,s ability to protect the cells in its body from ...
(Date:9/18/2014)... N.Y. A sleep-promoting circuit located deep in the ... sleep. Discovered by researchers at Harvard School of Medicine ... Biomedical Sciences, this is only the second "sleep node" ... be both necessary and sufficient to produce deep sleep. ... , the study demonstrates that fully half of all ...
(Date:9/18/2014)... "frequent flyers" program, fruit flies surely would be eligible ... increasing numbers of fruit fly research studies. One fruit ... and another is scheduled launch to the station Sept. ... December. , Fruit flies are biomedical research models studied ... organisms can reveal the basis for health and disease ...
Breaking Biology News(10 mins):Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4
... 11 genotypes that may increase esophageal cancer risk, according ... Cancer Prevention Research, a journal of the American ... increased risk of esophageal cancer with increasing numbers of ... the Department of Epidemiology at the University of Texas ...
... in Genome Research on Nov. 4, scientists at ... previously believed to be "junk" DNA is one of the ... 50 percent of human DNA has been referred to as ... A major source of these repeats is internal viruses that ...
... online, open-access journal PLoS ONE , led by ... children who study a musical instrument for at least ... in tests of auditory discrimination and finger dexterity (skills ... also on tests measuring verbal ability and visual pattern ...
Cached Biology News:Genetic predictors of esophageal cancer identified 2'Junk' DNA proves functional 2'Junk' DNA proves functional 3Research shows that time invested in practicing pays off for young musicians 2
... Vector NTI allows you to store and ... data in a secure central relational database. ... creates an invaluable resource for clone tracking ... easily for immediate analysis. LabShare software integrates ...
... Protein A and Protein G bind ... immunoglobulins. Protein A and Protein G conjugates ... purify immunoglobulins (antibodies) and immunoglobulin subtypes from ... and other biological fluids. These reagents are ...
... Description: ,Kit containing Dermal Fibroblasts (Mouse/BalbC) ... as a long-term culture, and is guaranteed ... continuous growth from the date supplied, when ... Dermis, mouse/BalbC, embryonic day 18.5 ,Applications: ...
... Protein A and Protein G bind specifically ... Protein A and Protein G conjugates are ... immunoglobulins (antibodies) and immunoglobulin subtypes from serum, ... other biological fluids. These reagents are also ...
Biology Products: